What is Design Therapeutics Inc (DSGN)?
Design Therapeutics Inc is a biotechnology company focused on the development of novel therapies for rare genetic diseases. The company employs advanced genetic and molecular biology techniques to identify and develop treatments targeting underlying causes of these conditions. Its research pipeline includes programs aimed at addressing disorders with significant unmet medical needs. Design Therapeutics operates within the biopharmaceutical sector, collaborating with academic institutions and other industry partners to advance its therapeutic candidates through various stages of development. The company’s activities encompass drug discovery, preclinical research, and clinical development, with an emphasis on precision medicine approaches.
Design Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by intraday fluctuations, as Design Therapeutics Inc trades at $10.78. Its price has varied from $10.21 to $10.92 during the day, showing a daily change of +3.7901%.
FAQ: Design Therapeutics Inc (DSGN)
What is the current price of DSGN stock?
The current price is $10.78.
Does DSGN pay dividends?
The company does not currently pay dividends.
Does DSGN have a formal corporate presence or regional headquarters in the UAE?
Design Therapeutics Inc does not have an official regional office or subsidiary in the UAE and operates primarily from the U.S.
What is DSGN best known for?
The company is most famous for its development of gene therapy treatments.
What assets are typically shown together with DSGN?
Commonly shown alongside DSGN: JPMorgan Chase & Co, UBS CMCI Composite SF UCITS ETF, Amundi Smart Overnight Return
Latest shares articles



